Trials / Completed
CompletedNCT02764307
Aerosol Delivery in Different Types of Nebulizers
Evaluation of Aerosol Delivery in Different Types of Nebulizers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Chang Gung University · Academic / Other
- Sex
- All
- Age
- 20 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
Background: Nebulizers design influences efficiency of aerosol delivery. Performance of nebulizers is commonly tested by breathing simulators with static parameters. However, breathing patterns vary in adults. Objectives: The purpose of this study was to evaluate drug deposition of different types of nebulizers testing with breathing patterns of healthy subjects.
Detailed description
Material and Methods The study was approved by Chang Gung Memorial Foundation Institutional Review Broad. Ten healthy subjects, aged 20.6±0.5 years, were recruited. Four nebulizers: 1. a constant jet nebulizer (Neb-easy, Galemed Corp., Taiwan); 2. a breath enhanced nebulizer (Pari LC plus, Pari Inc., Germany); 3. a manual-actuated nebulizer (A-T Neb, Atlantean Corporation, Taiwan); and 4. a breath-actuated nebulizer (AeroElipes, Trudell Medical Inc, Canada) were evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Constant jet nebulizer | A constant jet nebulizer (Neb-easy, Galemed Corp., Taiwan) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min. |
| DEVICE | Breath enhanced nebulizer | A breath enhanced nebulizer (Pari LC plus, Pari Inc., Germany) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min. |
| DEVICE | Manual-actuated nebulizer | A manual-actuated nebulizer (A-T Neb, Atlantean Corporation, Taiwan) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min. |
| DEVICE | Breath-actuated nebulizer | A breath-actuated nebulizer (AeroElipes, Trudell Medical Inc, Canada) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-10-01
- Completion
- 2016-12-01
- First posted
- 2016-05-06
- Last updated
- 2017-02-01
Source: ClinicalTrials.gov record NCT02764307. Inclusion in this directory is not an endorsement.